These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27589358)

  • 1. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N
    Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A; Fournier A; Spigelblatt L; Saint-Cyr C; Mir TS; Nir A; Dallaire F; Cousineau J; Delvin E; Dahdah N
    Pediatr Int; 2012 Oct; 54(5):627-33. PubMed ID: 22414326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
    Rodríguez-González M; Castellano-Martínez A; Alonso-Ojembarrena A
    Emergencias; 2019 Abr; 31(2):111-114. PubMed ID: 30963739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
    Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L; Dionne A; Meloche-Dumas L; Fournier A; Dahdah N
    Pediatr Cardiol; 2020 Jun; 41(5):947-954. PubMed ID: 32172336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M
    Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
    Cho SY; Kim Y; Cha SH; Suh JT; Han MY; Lee HJ
    Ann Clin Lab Sci; 2011; 41(4):360-3. PubMed ID: 22166506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY; Ham EM; Kwon H; Kwak YH; Kim DK; Lee JH; Jung JH
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L; Chen Y; Zhong S; Li Y; Dai X; Di Y
    Indian Pediatr; 2015 Jun; 52(6):477-80. PubMed ID: 26121721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M; Ayusawa M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
    Yanagisawa D; Ayusawa M; Kato M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2016 Nov; 58(11):1105-1111. PubMed ID: 26991905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
    Dahdah N; Siles A; Fournier A; Cousineau J; Delvin E; Saint-Cyr C; Spiegelblatt L; Bonny Y; Vartian M; Montigny M
    Pediatr Cardiol; 2009 Aug; 30(6):810-7. PubMed ID: 19365652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease.
    Rodriguez-Gonzalez M; Perez-Reviriego AA; Castellano-Martinez A; Cascales-Poyatos HM
    Biomark Med; 2019 Mar; 13(4):307-323. PubMed ID: 30900472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH; Song ES; Yoon S; Hong S; Cho HJ; Yang EM; Eom GH; Kang G; Cho YK
    Dis Markers; 2017; 2017():6263121. PubMed ID: 29358841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.